GlassScriptPhysician profile
Sean Leo Mccagh
NPI 1518950344
$917.91
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $92.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $367.88 | 2019 | |
| Abbvie INC. | $177.59 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $75.29 | 2019-2020 | |
| Celgene Corporation | $63.57 | 2019 | |
| Janssen Biotech, INC. | $42.17 | 2019 | |
| Pfizer INC. | $31.99 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $29.95 | 2019 | |
| Dermira, INC. | $24.91 | 2019 | |
| Genentech USA, INC. | $21.24 | 2019 | |
| Leo Pharma INC. | $19.89 | 2019 | |
| Galderma Laboratories, L.P. | $13.00 | 2019 | |
| Aclaris Therapeutics, INC. | $12.96 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $12.82 | 2019 | |
| Merck Sharp & Dohme LLC | $12.80 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mccagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.